Showing results (61-70 of 482) with videos related to
Sort By:
Pageof 49
Expert Opinion on Investigational Drugs|February 17, 2021
Targeting Ebola virus replication through pharmaceutical interventionFrederick Hansen, Heinz Feldmann, Michael A JarvisElife|February 22, 2022
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concernDavid W Hawman, Kimberly Meade-White, Jacob Archer, et al.Emerging Microbes & Infections|May 25, 2026
Hantavirus seroprevalence and associated factors for exposure in south-central UgandaGerald Katushabe, Victor Ssempijja, Deepashri Rao, et al.Nature Communications|April 17, 2021
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster modelKyle Rosenke, Frederick Hansen, Benjamin Schwarz, et al.Science Translational Medicine|August 7, 2024
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical modelsNikole L Warner, Jacob Archer, Stephanie Park, et al.Current Topics in Microbiology and Immunology|April 6, 2012
Animal challenge models of henipavirus infection and pathogenesisThomas W Geisbert, Heinz Feldmann, Christopher C BroderFuture Virology|November 3, 2011
Clinical aspects of Marburg hemorrhagic feverMasfique Mehedi, Allison Groseth, Heinz Feldmann, et al.Reviews in Medical Virology|July 27, 2010
Prospects for immunisation against Marburg and Ebola virusesThomas W Geisbert, Daniel G Bausch, Heinz FeldmannJournal of Virology|April 30, 2003
Reverse genetics for crimean-congo hemorrhagic fever virusRamon Flick, Kirsten Flick, Heinz Feldmann, et al.Journal of Visualized Experiments : Jove|October 7, 2014
Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomesThomas Hoenen, Ari Watt, Anita Mora, et al.Pageof 49